Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.74 |
| ▸ | CA9 | Q16790 | 6/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | NSD2 | O96028 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7073805 | 0.90 | CA9 (0.58) | CA12CA9TSHRALDH1A1HTT | |
| SCHEMBL7072113 | 0.87 | MMP2 (0.63) | CA12CA9TSHRALDH1A1HTT | |
| SCHEMBL7072853 | 0.82 | MMP2 (0.63) | TSHRALDH1A1HTTNSD2CNR1 | |
| SCHEMBL975460 | 0.81 | CA9 (0.73) | CA12CA9ALDH1A1FABP4 | |
| SCHEMBL7072870 | 0.81 | HTT (0.58) | CA12CA9TSHRALDH1A1HTT | |
| SCHEMBL7459434 | 0.80 | TSHR (0.56) | CA12CA9TSHRALDH1A1HTT | |
| SCHEMBL6483736 | 0.80 | NSD2 (0.76) | TSHRALDH1A1HTTNSD2CNR1 | |
| SCHEMBL3659182 | 0.79 | ALDH1A1 (0.88) | CA12CA9TSHRALDH1A1HTT | |
| SCHEMBL7076489 | 0.79 | MMP12 (0.68) | TSHRALDH1A1HTTNSD2CNR1 | |
| SCHEMBL8359828 | 0.77 | NSD2 (0.58) | TSHRALDH1A1HTTNSD2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003525203-A | — | — | 2003-08-26 | — | — | JP | claimed |
| US-20030022893-A1 | Hydroxamic and carboxylic acid derivatives | BAXTER ANDREW DOUGLAS (GB) | 2003-01-30 | — | — | US | claimed |
| EP-1163213-A1 | HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES | Darwin Discovery Limited (GB) | 2001-12-19 | — | — | EP | claimed |
| WO-2000056704-A1 | HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES | DARWIN DISCOVERY LIMITED (GB) | 2000-09-28 | — | — | WO | claimed |
| CN-101828111-B | Human T2R bitter taste receptor and uses thereof | SENOMYX INC | 2014-07-23 | — | — | CN | disclosed |
| CN-101828111-A | Human T2R bitter taste receptor and uses thereof | SENOMYX INC | 2010-09-08 | — | — | CN | disclosed |
| US-7345051-B2 | Mucin synthesis inhibitors | GENAERA CORPORATION (US) | 2008-03-18 | — | — | US | disclosed |
| US-20030022893-A1 | Hydroxamic and carboxylic acid derivatives | BAXTER ANDREW DOUGLAS (GB) | 2003-01-30 | — | — | US | disclosed |
| US-6465468-B1 | SUCH AS N-HYDROXY-2-(4-(4-CHLOROPHENYL)PIPERAZINE-1-SULFONYL)BENZAMIDE; INHIBITORS OF MATRIX METALLOPROTEINASE, ADAM OR ADAMTS ENZYMES; TREATMENT OF DEGENERATIVE DISEASES AND CERTAIN CANCERS | DARWIN DISCOVERY LIMITED (GB) | 2002-10-15 | — | — | US | disclosed |